Healthcare has spent a decade adopting AI.
It has not spent a decade
operationalizing it.
That distinction is the whole story.
The most sophisticated diagnostic tools
in human history sit inside systems
that still cannot reliably say
whether a patient understood
their discharge instructions.
The operationalization gap is the space
between what AI produces
and what an institution can stand behind.
The technology problem was a data problem.
The data problem was a structural one.
Each layer wears the name
of the layer above it.
The real one stays hidden
until it reaches a patient.
Every health system has an AI story.
Most of them sound the same.
A pilot launched.
Results were promising.
The board was impressed.
And the workflow never changed.
The AI kept generating outputs.
Physicians kept synthesizing by hand.
Patients kept leaving without clarity.
The system measured adoption
while the gap between what the AI knew
and what the institution could deliver
stayed exactly where it was.
That is not failure.
It is a gap nobody designed for.
Adoption means you have the tools.
Operationalization means the tools
are embedded in workflows
with accountability at every step,
outcomes measurable at scale,
and a layer that makes every
clinical decision defensible.
Most investments produced the first.
Almost none produced the second.
The reason is not capability.
Healthcare is not a generic workflow.
Every clinical decision carries liability.
Every output needs a human
who can stand behind it.
The moment an AI output
shapes a clinical decision,
someone has to own that decision.
Document it. Defend it.
Answer for what follows.
That someone is a clinician.
And right now nothing connects
what the AI produces
to the clinician who has to stand behind it.
The output generates.
The clinician synthesizes alone.
The accountability lives in their head.
That is the operationalization gap
in clinical terms.
It is why pilots stall.
Not because the AI did not work.
Because no one built the layer
that connects what the AI produces
to a decision a clinician can defend.
The enterprise world is moving
into the agentic era.
AI is shifting from assistant to executor.
Not helping the human decide.
Doing the work.
The value created will not flow
to whoever deploys the most agents.
It flows to whoever can ground them.
Domain workflows built over years.
Accountability a regulated industry
will actually accept.
Infrastructure that runs inside
the rules institutions live by.
Apply that to healthcare
and the conclusion is unavoidable.
Agents executing clinical workflows
with no judgment layer beneath them
is not agentic healthcare.
It is agentic liability.
The governance layer gets dismissed
the same way data governance always was.
Red tape. Compliance theater.
That read is wrong, and it is expensive.
The accountable layer is what
makes yes possible.
Safely. Consistently.
With ownership at every step.
Output routed through a judgment layer
before it reaches a clinical decision.
A clinician who can synthesize
in a fraction of the time,
with the context and the audit trail
already built in.
A patient who receives a decision
someone is accountable for.
Without it, AI produces outputs.
With it, AI produces decisions.
Three questions every institution
should be asking now.
Where does AI output become
a clinical decision in your workflow.
That is where your gap lives.
Who owns the accountability
between the output and the decision.
If the answer is nobody, or it depends,
the accountability was never built.
Can the workflow scale
beyond the team that ran the pilot.
If not, the accountability
was never structural.
It was incidental.
And incidental accountability
does not survive scale.
The operationalization gap is not
a tool you can buy your way out of.
It is the judgment layer
that connects what AI produces
to decisions an institution can stand behind.
That layer does not exist
in most health systems today.
Building it is the most important thing
happening in healthcare AI right now.
You already know where your gap lives.
The point in your workflow where the output
becomes a decision, and no one is named.
The only question is whether you build
the layer before the next pilot stalls there.
MedicoVigilance™ is published every two weeks by Mo Johnson, MD MBA, founder of GPe Research. Each issue teaches one piece of the clinical AI accountability discipline your institution needs before the next deployment decision.
Forward this to a colleague whose institution is running on output no one has been named to own.